PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 16, 20240 citations

Figure S1 from BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

View Full Paper
SLSun Min LimTFToshio FujinoCKChulwon Kim

Key Points

Key points are not available for this paper at this time.

Abstract

Supplementary Figure 1. Growth inhibition by BBT-176 with and without cetuximab in EGFR 19Del and EGFR L858R-derived mutants. Abbreviation: N/E, not evaluable.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lim et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db643587523ae2https://doi.org/10.1158/1078-0432.27032026.v1
Ask AI
Helpful
Bookmark
Share
View Full Paper